Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
9.30
-0.58 (-5.87%)
Nov 16, 2026, 9:51 AM EST - Market open

Biodesix Revenue

Biodesix had revenue of $24.04M in the quarter ending September 30, 2026, with 10.44% growth. This brings the company's total for the last twelve months to $105.21M, up 31.23% year-over-year. In the year 2025, Biodesix had annual revenue of $88.50M with 24.08% growth. That makes Biodesix the 22,310th largest company in the world by revenue and 3,259th in the United States.

Revenue (ttm)
$105.21M
Revenue Growth
+31.23%
P/S Ratio
1.04
Revenue / Employee
$315,006
Employees
334
Market Cap
103.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202588.50M17.18M24.08%
Dec 31, 202471.32M22.24M45.30%
Dec 31, 202349.09M10.88M28.46%
Dec 31, 202238.21M-16.29M-29.89%
Dec 31, 202154.51M8.95M19.64%
Dec 31, 202045.56M21.01M85.55%
Dec 31, 201924.55M4.12M20.16%
Dec 31, 201820.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics803.60M
OPKO Health654.10M
Castle Biosciences377.13M
Fulgent Genetics330.28M
Freenome217.86M
MDxHealth114.01M
Burning Rock Biotech73.70M
Exagen72.30M
Revenue Rankings